240 related articles for article (PubMed ID: 19130396)
1. Expression of enzymes involved in synthesis and metabolism of estradiol in human breast as studied by immunocytochemistry and in situ hybridization.
Li Z; Luu-The V; Poisson-Paré D; Ouellet J; Li S; Labrie F; Pelletier G
Histol Histopathol; 2009 Mar; 24(3):273-82. PubMed ID: 19130396
[TBL] [Abstract][Full Text] [Related]
2. New development in intracrinology of breast carcinoma.
Sasano H; Suzuki T; Nakata T; Moriya T
Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
[TBL] [Abstract][Full Text] [Related]
3. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
4. Estrogen metabolizing enzymes in endometrium and endometriosis.
Dassen H; Punyadeera C; Kamps R; Delvoux B; Van Langendonckt A; Donnez J; Husen B; Thole H; Dunselman G; Groothuis P
Hum Reprod; 2007 Dec; 22(12):3148-58. PubMed ID: 17921479
[TBL] [Abstract][Full Text] [Related]
5. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits cell proliferation through in situ production in human thymoma.
Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
[TBL] [Abstract][Full Text] [Related]
7. Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study.
Song D; Liu G; Luu-The V; Zhao D; Wang L; Zhang H; Xueling G; Li S; Désy L; Labrie F; Pelletier G
J Steroid Biochem Mol Biol; 2006 Oct; 101(2-3):136-44. PubMed ID: 16930994
[TBL] [Abstract][Full Text] [Related]
8. Expression of enzymes involved in estrogen metabolism in human prostate.
Takase Y; Lévesque MH; Luu-The V; El-Alfy M; Labrie F; Pelletier G
J Histochem Cytochem; 2006 Aug; 54(8):911-21. PubMed ID: 16651392
[TBL] [Abstract][Full Text] [Related]
9. In vitro interactions between mammary fibroblasts (Hs 578Bst) and cancer epithelial cells (MCF-7) modulate aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases.
Wang X; Sang X; Diorio C; Lin SX; Doillon CJ
Mol Cell Endocrinol; 2015 Sep; 412():339-48. PubMed ID: 26044867
[TBL] [Abstract][Full Text] [Related]
10. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
Fournier MA; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):142-5. PubMed ID: 18817841
[TBL] [Abstract][Full Text] [Related]
11. Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.
Ren X; Wu X; Hillier SG; Fegan KS; Critchley HO; Mason JI; Sarvi S; Harlow CR
J Steroid Biochem Mol Biol; 2015 Jun; 150():54-63. PubMed ID: 25817828
[TBL] [Abstract][Full Text] [Related]
12. Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry.
El-Alfy M; Luu-The V; Huang XF; Berger L; Labrie F; Pelletier G
Endocrinology; 1999 Mar; 140(3):1481-91. PubMed ID: 10067877
[TBL] [Abstract][Full Text] [Related]
13. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
14. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-metabolizing enzymes in breast cancers from women over the age of 80 years.
Honma N; Takubo K; Sawabe M; Arai T; Akiyama F; Sakamoto G; Utsumi T; Yoshimura N; Harada N
J Clin Endocrinol Metab; 2006 Feb; 91(2):607-13. PubMed ID: 16303840
[TBL] [Abstract][Full Text] [Related]
16. Specific estradiol biosynthetic pathway in choriocarcinoma (JEG-3) cell line.
Samson M; Labrie F; Luu-The V
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):154-9. PubMed ID: 19465125
[TBL] [Abstract][Full Text] [Related]
17. Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer.
Smuc T; Rizner TL
Mol Cell Endocrinol; 2009 Mar; 301(1-2):74-82. PubMed ID: 18930784
[TBL] [Abstract][Full Text] [Related]
18. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
19. Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters.
Han B; Li S; Song D; Poisson-Paré D; Liu G; Luu-The V; Ouellet J; Li S; Labrie F; Pelletier G
J Steroid Biochem Mol Biol; 2008 Dec; 112(4-5):194-200. PubMed ID: 18996480
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of progestins on breast tissue enzymes.
Pasqualini JR
Maturitas; 2003 Dec; 46 Suppl 1():S45-54. PubMed ID: 14670645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
